世界各国高血压临床指南的现状分析和循证评价  

Analysis on current status of clinical guidelines for hypertension in the world and evaluation on evidence-based clinical guidelines with Appraisal of Guidelines for Research and Evaluation instrument

作　　者：唐海沁[1] 符赵鑫[1] 张勇[1] 丁琳[1] 李瑾[1] 

机构地区：[1]安徽医科大学第一附属医院老年心血管科,合肥230022

出　　处：《中华老年医学杂志》2014年第8期852-858,共7页Chinese Journal of Geriatrics

基　　金：安徽省科技攻关项目（12010402116）

摘　　要：目的 调查分析世界各国高血压临床指南现状,采用AGREEⅡ工具评价世界各国高血压防治指南的质量,为高血压临床指南的应用、制定提供参考. 方法 计算机检索中国知网、万方数据库、美国国立医学图书馆PubMed数据库、Medline、Embase及相关机构认可和授权的网站1995-2012年公开发表的国内外高血压防治临床指南及指南相关资料,按照纳入和排除标准筛选指南.描述性分析纳入指南的名称、发表年份及机构、开发方法、参考文献数目等内容.采用AGREEⅡ工具评价世界各国最新版高血压临床指南的质量. 结果 共纳入高血压防治临床指南9部.评价结果表明,世界各国高血压防治指南在清晰性与可读性领域平均得分最高,为88.4％;其次为适用性领域,平均得分86.1％;范围和目的领域平均得分83.8％;参与人员领域平均得分71.7％;编辑的独立性领域平均得分为64.1％;严谨性领域平均得分最低,为62.9％.整体评估结果显示,英国2011版、加拿大2012版、欧洲2009版、澳大利亚2010版为积极推荐使用的指南,美国第7版、日本2009版、中国台湾2010版、中国2010版、南非2011版为推荐使用的指南（尚需补充和改进）,无不推荐或不确定的指南. 结论 世界范围内高血压指南总体质量较高,但亚洲和非洲国家制定的指南在严谨性、编辑独立性存在一些有共性的不足之处,与循证医学要求仍存在差距,内容尚需规范、质量有待提高.建立和完善一套科学、系统、适用于本国或本地域现状的高血压临床指南评价体系,以推动开发出以高血压指南为代表的高质量慢性病防治指南,提高慢性病防治指南的推广和应用.Objective To assess and analyze the current status of clinical guidelines for hypertension in the world by using the Appraisal of Guidelines for Research and Evaluation （AGREE） instrument.Methods The clinical guidelines for hypertension were identified and approved by searching China hownet,WANFANG database,PUBMED database,MEDLINE,Embase and related institutions and authorization web site from 1995 to January 2012,and relevant Web sites of agencies and organizations that produce and/or endorse guidelines.Names of the guidelines,published years and organizations,methodology of development and reference number were descriptively analyzed.AGREE instrument was used to evaluate the qualities of latest edited clinical guidelines for hypertension in countries all over the world.Results Nine guidelines were enrolled.The results showed that the hypertension guidelines scored the highest average of 88.4% for clarity of presentation and reliability field; for applicability fields,scored an average of 86.1%; the scope and goal field scored an average of 83.8%; participants field scored an average of 71.7%; editorial independence field scored an average of 64.1% ; rigor of development field scored the lowest average of 62.9%.The overall assessment showed that NICE 2011,Canada 2012,ESC 2009,Australia 2010 editions were the positively recommended guidelines,JNC7,Japan 2009,China Taiwan 2010,China 2010,South Africa 2011 editions were the recommended guidelines （still need to supplement and improve）.No recommend or uncertain guide was found.Conclusions The quality of the hypertension guidelines is higher in general,but some common deficiency in the rigor of development and editorial independence in Asian and African guidelines formulated by the states still exists.There still exist certain gaps in evidence-based medical requirement.And the contents and quality are needed for further regulating and enhancing.A set of scientific systemic hypertension clinical guidelines evaluation system should be established.

关 键 词：循证医学 高血压 方案评价 

分 类 号：R544.1[医药卫生—心血管疾病]